VIDEO INTERVIEW
The ACRI medical technologies research team, recipients of an NBIF Innovation Research Chair, is investigating the use of microwaves as an energy source for the detection and treatment of cancer. This research subject is a core disruptive technology that will lead to the development of new, non-invasive treatments and more precise screening methods in the detection of cancer. Specifically, the team is investigating the properties of diseased tissues to guide them in the selection of conditions that will lead to improved ablation efficiencies. The RD&D team is now making significant inroads in the validation of the technology by performing in vivo animal clinical trials. In order to bring these results to fruition, in 2018-19 the Chair has put together a team of collaborators encompassing various specializations such as veterinarians, interventional radiologists, electrical engineers, immunology specialists, molecular genetics specialists, bioinformatics specialists, and microwave specialists. This research will lead to the improvement of microwave ablation technologies by allowing unparalleled control on the shape and penetration of the microwaves used to ablate diseased tissues, thereby leading to less collateral damage to healthy tissues, while reducing recovery time for the patient.
- Jacqueline M. R. Bélanger, Ph. D. - Research Scientist
